Clearance of atypical cutaneous manifestations of <scp>hyper‐IgE</scp> syndrome with dupilumab-Reference-Cited by-同舟云学术

Clearance of atypical cutaneous manifestations of hyper‐IgE syndrome with dupilumab

Published:2022-06-22 Issue:6 Volume:39 Page:940-942
ISSN:0736-8046
Container-title:Pediatric Dermatology
language:en
Short-container-title:Pediatric Dermatology

Author:

Nihal Aman¹^ORCID,Comstock Jeanette R.¹,Holland Kristen E.²,Singh Anne Marie¹³,Seroogy Christine M.³,Arkin Lisa M.¹

Affiliation:

1. Department of Dermatology, School of Medicine and Public Health University of Wisconsin‐Madison Madison Wisconsin USA

2. Department of Dermatology Medical College of Wisconsin Milwaukee Wisconsin USA

3. Division of Allergy, Immunology & Rheumatology, Department of Pediatrics, School of Medicine and Public Health University of Wisconsin‐Madison Madison Wisconsin USA

Publisher

Wiley

Subject

Dermatology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pde.15072

Reference18 articles.

1. Off-label use of dupilumab for pediatric patients with atopic dermatitis: A multicenter retrospective review

2. Hyper IgE syndromes: clinical and molecular characteristics

3. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome

4. STAT3Mutations in the Hyper-IgE Syndrome

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monogenic Inborn Errors of Immunity with impaired IgG response to polysaccharide antigens but normal IgG levels and normal IgG response to protein antigens;Frontiers in Pediatrics;2024-06-12

2. Management of Atopy with Dupilumab and Omalizumab in CADINS Disease;Journal of Clinical Immunology;2024-01-17

3. The trajectory of human B‐cell function, immune deficiency, and allergy revealed by inborn errors of immunity;Immunological Reviews;2023-11-20

4. Omalizumab and dupilumab for the treatment of autosomal-recessive DOCK8 hyper-IgE syndrome;Indian Journal of Dermatology, Venereology and Leprology;2023-10-17

5. Atopic manifestations of inborn errors of immunity;Current Opinion in Allergy & Clinical Immunology;2023-09-26